Join
Live feed
·
INSIDERFilingvia Quantisnow
Lexicon Pharmaceuticals Inc. logo

Director Invus Global Management, Llc was granted 22,400,000 shares, bought $2,000,001 worth of shares (1,538,462 units at $1.30) and was granted 367,145 units of Series B Convertible Preferred Stock (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LXRX (Lexicon Pharmaceuticals Inc.) and more on Quantisnow.